However, our data provide evidence that blocking of the enzymatic activity of PLD has no translational potential in patients with MI because inhibition of PLD enzymatic activity does lead to neither altered cardiac function nor to altered infarct size, at least in mice. Here, GPLD1 is linked to myocardial infarction.